|
1
|
Mohammadi M, Olsen SK and Ibrahimi OA:
Structural basis for fibroblast growth factor receptor activation.
CytokineGrowth Factor Rev. 16:107–137. 2005. View Article : Google Scholar
|
|
2
|
Feldman B, Poueymirou W, Papaioannou VE,
DeChiara TM and Goldfarb M: Requirement of FGF-4 for
postimplantation mouse development. Science. 267:246–249. 1995.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Dubrulle J and Pourquié O: fgf8 mRNA decay
establishes a gradient that couples axial elongation to patterning
in the vertebrate embryo. Nature. 427:419–422. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Sun X, Meyers EN, Lewandoski M and Martin
GR: Targeted disruption of Fgf8 causes failure of cell migration in
the gastrulating mouse embryo. Genes Dev. 13:1834–1846. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Martin GR: The roles of FGFs in the early
development of vertebrate limbs. Genes Dev. 12:1571–1586. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Goldfarb M: Functions of fibroblast growth
factors in vertebrate development. Cytokine Growth Factor Rev.
7:311–325. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Kanazawa S, Fujiwara T, Matsuzaki S,
Shingaki K, Taniguchi M, Miyata S, Tohyama M, Sakai Y, Yano K,
Hosokawa K and Kubo T: bFGF regulates PI3-kinase-Rac1-JNK pathway
and promotes fibroblast migration in wound healing. PloS One.
5:e122282010. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Yie J, Wang W, Deng L, Tam LT, Stevens J,
Chen MM, Li Y, Xu J, Lindberg R, Hecht R, et al: Understanding the
physical interactions in the FGF21/FGFR/beta-Klotho complex:
Structural requirements and implications in FGF21 signaling. Chem
Biol Drug Des. 79:398–410. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Belov AA and Mohammadi M: Molecular
mechanisms of fibroblast growth factor signaling in physiology and
pathology. Cold Spring Harb Perspect Biol. 5:a0159582013.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Nishimura T, Nakatake Y, Konishi M and
Itoh N: Identification of a novel FGF, FGF-21, preferentially
expressed in the liver. Biochim Biophys Acta. 1492:203–206. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Liang Q, Zhong L, Zhang J, Wang Y,
Bornstein SR, Triggle CR, Ding H, Lam KS and Xu A: FGF21 maintains
glucose homeostasis by mediating the cross talk between liver and
brain during prolonged fasting. Diabetes. 63:4064–4075. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Lin Z, Tian H, Lam KS, Lin S, Hoo RC,
Konishi M, Itoh N, Wang Y, Bornstein SR, Xu A and Li X: Adiponectin
mediates the metabolic effects of FGF21 on glucose homeostasis and
insulin sensitivity in mice. Cell Metab. 17:779–789. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Lin Z, Wu F, Lin S, Pan X, Jin L, Lu T,
Shi L, Wang Y, Xu A and Li X: Adiponectin protects against
acetaminophen-induced mitochondrial dysfunction and acute liver
injury by promoting autophagy in mice. J Hepatol. 61:825–831. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Song Y, Ding J, Jin R, Jung J, Li S, Yang
J, Wang A and Li Z: Expression and purification of FGF21 in Pichia
pastoris and its effect on fibroblast-cell migration. Mol Med Rep.
13:3619–3626. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Song YH, Zhu YT, Ding J, Zhou FY, Xue JX,
Jung JH, Li ZJ and Gao WY: Distribution of fibroblast growth
factors and their roles in skin fibroblast cell migration. Mol Med
Rep. 14:3336–3342. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Gong Q, Hu Z, Zhang F, Cui A, Chen X,
Jiang H, Gao J, Chen X, Han Y, Liang Q, et al: Fibroblast growth
factor 21 improves hepatic insulin sensitivity by inhibiting
mammalian target of rapamycin complex 1 in mice. Hepatology.
64:425–438. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Inagaki T, Dutchak P, Zhao G, Ding X,
Gautron L, Parameswara V, Li Y, Goetz R, Mohammadi M, Esser V, et
al: Endocrine regulation of the fasting response by
PPARalpha-mediated induction of fibroblast growth factor 21. Cell
Metab. 5:415–425. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Wang Y, Solt LA and Burris TP: Regulation
of FGF21 expression and secretion by retinoic acid receptor-related
orphan receptor alpha. J Biol Chem. 285:15668–15673. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Li Y, Wong K, Walsh K, Gao B and Zang M:
Retinoic acid receptor β stimulates hepatic induction of fibroblast
growth factor 21 to promote fatty acid oxidation and control
whole-body energy homeostasis in mice. J Biol Chem.
288:10490–10504. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Shtutman M, Zhurinsky J, Simcha I,
Albanese C, D'Amico M, Pestell R and Ben-Ze'ev A: The cyclin D1
gene is a target of the beta-catenin/LEF-1 pathway. Proc Natl Acad
Sci USA. 96:pp. 5522–5527. 1999; View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Moon RT, Kohn AD, De Ferrari GV and Kaykas
A: WNT and β-catenin signalling: Diseases and therapies. Nat Rev
Genet. 5:691–701. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Clevers H: Wnt/beta-catenin signaling in
development and disease. Cell. 127:469–480. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Brack AS, Conboy MJ, Roy S, Lee M, Kuo CJ,
Keller C and Rando TA: Increased Wnt signaling during aging alters
muscle stem cell fate and increases fibrosis. Science. 317:807–810.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Gordon MD and Nusse R: Wnt signaling:
Multiple pathways, multiple receptors, and multiple transcription
factors. J Biol Chem. 281:22429–22433. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Aberle H, Bauer A, Stappert J, Kispert A
and Kemler R: beta-catenin is a target for the ubiquitin-proteasome
pathway. EMBO J. 16:3797–3804. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Schuijers J, Mokry M, Hatzis P, Cuppen E
and Clevers H: Wnt-induced transcriptional activation is
exclusively mediated by TCF/LEF. EMBO J. 33:146–156. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-tie quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Dutchak PA, Katafuchi T, Bookout AL, Choi
JH, Yu RT, Mangelsdorf DJ and Kliewer SA: Fibroblast growth
factor-21 regulates PPARγ activity and the antidiabetic actions of
thiazolidinediones. Cell. 148:556–567. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Fisher FM, Kleiner S, Douris N, Fox EC,
Mepani RJ, Verdeguer F, Wu J, Kharitonenkov A, Flier JS,
Maratos-Flier E and Spiegelman BM: FGF21 regulates PGC-1α and
browning of white adipose tissues in adaptive thermogenesis. Genes
Dev. 26:271–281. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Shu W, Guttentag S, Wang Z, Andl T,
Ballard P, Lu MM, Piccolo S, Birchmeier W, Whitsett JA, Millar SE
and Morrisey EE: Wnt/beta-catenin signaling acts upstream of N-myc,
BMP4, and FGF signaling to regulate proximal-distal patterning in
the lung. Dev Biol. 283:226–239. 2005. View Article : Google Scholar : PubMed/NCBI
|
